Trial Profile
Efficacy and Safety of Racecadotril in the Treatment of Taiwanese Children Aged 3 to 60 Months Suffering From Acute Diarrhea: A Prospective, Open-label, Multicenter, Single-arm Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2023
Price :
$35
*
At a glance
- Drugs Racecadotril (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 14 Dec 2021 Status changed from recruiting to completed.
- 28 Jan 2020 Planned End Date changed from 1 Sep 2019 to 1 Dec 2020.
- 28 Jan 2020 Planned primary completion date changed from 1 Aug 2019 to 1 Dec 2020.